Search Results - "Halloran, P. F."

Refine Results
  1. 1

    Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and Nonadherence by Sellarés, J., de Freitas, D. G., Mengel, M., Reeve, J., Einecke, G., Sis, B., Hidalgo, L. G., Famulski, K., Matas, A., Halloran, P. F.

    Published in American journal of transplantation (01-02-2012)
    “…We prospectively studied kidney transplants that progressed to failure after a biopsy for clinical indications, aiming to assign a cause to every failure. We…”
    Get full text
    Journal Article
  2. 2

    NK Cell Transcripts and NK Cells in Kidney Biopsies from Patients with Donor‐Specific Antibodies: Evidence for NK Cell Involvement in Antibody‐Mediated Rejection by Hidalgo, L. G., Sis, B., Sellares, J., Campbell, P. M., Mengel, M., Einecke, G., Chang, J., Halloran, P. F.

    Published in American journal of transplantation (01-08-2010)
    “…To explore the mechanisms of antibody‐mediated rejection (ABMR) in kidney transplants, we studied the transcripts expressed in clinically indicated biopsies…”
    Get full text
    Journal Article
  3. 3

    Molecular Diagnosis of Antibody‐Mediated Rejection in Human Kidney Transplants by Sellarés, J., Reeve, J., Loupy, A., Mengel, M., Sis, B., Skene, A., de Freitas, D. G., Kreepala, C., Hidalgo, L. G., Famulski, K. S., Halloran, P. F.

    Published in American journal of transplantation (01-04-2013)
    “…Antibody‐mediated rejection is the major cause of kidney transplant failure, but the histology‐based diagnostic system misses most cases due to its requirement…”
    Get full text
    Journal Article
  4. 4

    Molecular Diagnosis of T Cell‐Mediated Rejection in Human Kidney Transplant Biopsies by Reeve, J., Sellarés, J., Mengel, M., Sis, B., Skene, A., Hidalgo, L., de Freitas, D. G., Famulski, K. S., Halloran, P. F.

    Published in American journal of transplantation (01-03-2013)
    “…Histologic diagnosis of T cell‐mediated rejection is flawed by subjective assessments, nonspecific lesions and arbitrary rules. This study developed a…”
    Get full text
    Journal Article
  5. 5

    Banff 2011 Meeting Report: New Concepts in Antibody‐Mediated Rejection by Mengel, M., Sis, B., Haas, M., Colvin, R. B., Halloran, P. F., Racusen, L. C., Solez, K., Cendales, L., Demetris, A. J., Drachenberg, C. B., Farver, C. F., Rodriguez, E. R., Wallace, W. D., Glotz, D.

    Published in American journal of transplantation (01-03-2012)
    “…The 11th Banff meeting was held in Paris, France, from June 5 to 10, 2011, with a focus on refining diagnostic criteria for antibody‐mediated rejection (ABMR)…”
    Get full text
    Journal Article
  6. 6

    De Novo Donor‐Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure by Hidalgo, L. G., Campbell, P. M., Sis, B., Einecke, G., Mengel, M., Chang, J., Sellares, J., Reeve, J., Halloran, P. F.

    Published in American journal of transplantation (01-11-2009)
    “…We studied whether de novo donor‐specific antibodies (DSA) in sera from patients undergoing kidney transplant biopsies associate with specific histologic…”
    Get full text
    Journal Article
  7. 7

    Molecular Landscape of T Cell–Mediated Rejection in Human Kidney Transplants: Prominence of CTLA4 and PD Ligands by Venner, J. M., Famulski, K. S., Badr, D., Hidalgo, L. G., Chang, J., Halloran, P. F.

    Published in American journal of transplantation (01-11-2014)
    “…We used expression microarrays to characterize the changes most specific for pure T cell–mediated rejection (TCMR) compared to other diseases including…”
    Get full text
    Journal Article
  8. 8

    T Cell‐mediated Rejection of Kidney Transplants: A Personal Viewpoint by Halloran, P. F.

    Published in American journal of transplantation (01-05-2010)
    “…In kidney allografts, T cell mediated rejection (TCMR) is characterized by infiltration of the interstitium by T cells and macrophages, intense IFNG and TGFB…”
    Get full text
    Journal Article
  9. 9

    Interpreting NK Cell Transcripts Versus T Cell Transcripts in Renal Transplant Biopsies by Hidalgo, L. G., Sellares, J., Sis, B., Mengel, M., Chang, J., Halloran, P. F.

    Published in American journal of transplantation (01-05-2012)
    “…NK cell transcripts are increased in biopsies with antibody‐mediated rejection, whereas T cell transcripts are increased in T cell‐mediated rejection. However,…”
    Get full text
    Journal Article
  10. 10

    Microarray Diagnosis of Antibody‐Mediated Rejection in Kidney Transplant Biopsies: An International Prospective Study (INTERCOM) by Halloran, P. F., Pereira, A. B., Chang, J., Matas, A., Picton, M., De Freitas, D., Bromberg, J., Serón, D., Sellarés, J., Einecke, G., Reeve, J.

    Published in American journal of transplantation (01-11-2013)
    “…In a reference set of 403 kidney transplant biopsies, we recently developed a microarray‐based test that diagnoses antibody‐mediated rejection (ABMR) by…”
    Get full text
    Journal Article
  11. 11

    A New Diagnostic Algorithm for Antibody‐Mediated Microcirculation Inflammation in Kidney Transplants by Sis, B., Jhangri, G. S., Riopel, J., Chang, J., de Freitas, D. G., Hidalgo, L., Mengel, M., Matas, A., Halloran, P. F.

    Published in American journal of transplantation (01-05-2012)
    “…We studied the significance of microcirculation inflammation in kidney transplants, including 329 indication biopsies from 251 renal allograft recipients, who…”
    Get full text
    Journal Article
  12. 12

    The Role of Donor‐Specific HLA Alloantibodies in Liver Transplantation by O'Leary, J. G., Demetris, A. J., Friedman, L. S., Gebel, H. M., Halloran, P. F., Kirk, A. D., Knechtle, S. J., McDiarmid, S. V., Shaked, A., Terasaki, P. I., Tinckam, K. J., Tomlanovich, S. J., Wood, K. J., Woodle, E. S., Zachary, A. A., Klintmalm, G. B.

    Published in American journal of transplantation (01-04-2014)
    “…The impact of donor‐specific HLA alloantibodies (DSA) on short‐ and long‐term liver transplant outcome is not clearly defined. While it is clear that not all…”
    Get full text
    Journal Article
  13. 13

    Potential Impact of Microarray Diagnosis of T Cell–Mediated Rejection in Kidney Transplants: The INTERCOM Study by Halloran, P. F., Pereira, A. B., Chang, J., Matas, A., Picton, M., De Freitas, D., Bromberg, J., Serón, D., Sellarés, J., Einecke, G., Reeve, J.

    Published in American journal of transplantation (01-09-2013)
    “…We previously developed a microarray‐based test for T cell‐mediated rejection (TCMR) in a reference set of 403 biopsies. To determine the potential impact of…”
    Get full text
    Journal Article
  14. 14

    Diagnosing Rejection in Renal Transplants: A Comparison of Molecular‐ and Histopathology‐Based Approaches by Reeve, J., Einecke, G., Mengel, M., Sis, B., Kayser, N., Kaplan, B., Halloran, P. F.

    Published in American journal of transplantation (01-08-2009)
    “…The transcriptome has considerable potential for improving biopsy diagnoses. However, to realize this potential the relationship between the molecular…”
    Get full text
    Journal Article
  15. 15

    Antibody‐Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure by Einecke, G., Sis, B., Reeve, J., Mengel, M., Campbell, P. M., Hidalgo, L. G., Kaplan, B., Halloran, P. F.

    Published in American journal of transplantation (01-11-2009)
    “…We studied the phenotype of late kidney graft failure in a prospective study of unselected kidney transplant biopsies taken for clinical indications. We…”
    Get full text
    Journal Article
  16. 16

    Inflammation in Areas of Tubular Atrophy in Kidney Allograft Biopsies: A Potent Predictor of Allograft Failure by Mannon, R. B., Matas, A. J., Grande, J., Leduc, R., Connett, J., Kasiske, B., Cecka, J. M., Gaston, R. S., Cosio, F., Gourishankar, S., Halloran, P. F., Hunsicker, L., Rush, D.

    Published in American journal of transplantation (01-09-2010)
    “…The Banff scoring schema provides a common ground to analyze kidney transplant biopsies. Interstitial inflammation (i) and tubulitis (t) in areas of viable…”
    Get full text
    Journal Article
  17. 17

    SWOT Analysis of Banff: Strengths, Weaknesses, Opportunities and Threats of the International Banff Consensus Process and Classification System for Renal Allograft Pathology by Mengel, M., Sis, B., Halloran, P. F.

    Published in American journal of transplantation (01-10-2007)
    “…The Banff process defined the diagnostic histologic lesions for renal allograft rejection and created a standardized classification system where none had…”
    Get full text
    Journal Article
  18. 18

    Treatment Responses in Histologic Versus Molecular Diagnoses of Lung Rejection by Zajacova, A, Mackova, M, Halloran, K, Gauthier, P, Balko, J, Guney, M, Rakita, D, Svorcova, M, Kolarik, J, Vachtenheim, Jr, J, Pozniak, J, Simonek, J, Fila, L, Lischke, R, Halloran, P F, Havlin, J

    Published in Transplant international (26-07-2024)
    “…Histologic evaluation of allograft biopsies after lung transplantation has several limitations, suggesting that molecular assessment using tissue…”
    Get full text
    Journal Article
  19. 19

    Transplant Glomerulopathy, Late Antibody‐Mediated Rejection and the ABCD Tetrad in Kidney Allograft Biopsies for Cause by Sis, B., Campbell, P. M., Mueller, T., Hunter, C., Cockfield, S. M., Cruz, J., Meng, C., Wishart, D., Solez, K., Halloran, P. F.

    Published in American journal of transplantation (01-07-2007)
    “…To define the relative frequency of phenotypes of transplant glomerulopathy, we retrospectively reviewed the findings in 1036 biopsies for clinical indications…”
    Get full text
    Journal Article
  20. 20

    The Nature of Biopsies with “Borderline Rejection” and Prospects for Eliminating This Category by de Freitas, D. G., Sellarés, J., Mengel, M., Chang, J., Hidalgo, L. G., Famulski, K. S., Sis, B., Einecke, G., Halloran, P. F.

    Published in American journal of transplantation (01-01-2012)
    “…In kidney transplantation, many inflamed biopsies with changes insufficient to be called T‐cell‐mediated rejection (TCMR) are labeled “borderline”, leaving…”
    Get full text
    Journal Article